Home/Filings/4/0000950170-24-005900
4//SEC Filing

Zakrzewski Joseph S 4

Accession 0000950170-24-005900

CIK 0001880438other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:32 PM ET

Size

17.2 KB

Accession

0000950170-24-005900

Insider Transaction Report

Form 4
Period: 2024-01-18
Transactions
  • Sale

    Common Stock

    2024-01-18$19.11/sh100,000$1,911,410405,880 total(indirect: See footnote)
Holdings
  • Common Stock

    98,199
Footnotes (1)
  • [F1]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001331852

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:32 PM ET
Size
17.2 KB